DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	EVPLL; LCE2B; FOXN1; KRT34; GJB5; KRT14; KRT5; DSP; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; FABP5; BNC1; KRT31; CDSN; CST6; CERS3; ACER1; GRHL3; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	36	82	43.9024390243902	0	0	0	0	0	0	0
down	HOXC11; GLI2; HOXB8; HOXD10; MSX1; HOXD3; HOXA11; HOXC8; HOXC13; HOXD13; MSX2; HNF1B; LHX1; EMX2; ALX1; CYP26C1; ALX4; HOXC10; HOXC5; HES4; HOXA6; HOXB6; HOXD9; HOXA7; HOXC9; HOXD4; HES2; HES5; HES7;	GO:0009952~anterior/posterior pattern specification	29	99	29.2929292929293	0	0	0	0	0	0	0
down	IL20RB; IL1A; IL36RN; IL1F10; IL36G; IL36B; IL37;	GO:0002437~inflammatory response to antigenic stimulus	7	25	28	0.0001102070242247	0.00691548560094813	0.379993819526788	0.385944998834923	0.340109237509239	0.379993819526788	0.060430610948719
down	CA2; KRT6A; KRT16; SERPINB5; TBX4; CA9;	GO:0002009~morphogenesis of an epithelium	6	17	35.2941176470588	0.00012088450299352	0.00739333798849301	0.416567997315682	0.423337529483319	0.359994049914713	0.416567997315682	0.0646062991633951
down	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	7	26	26.9230769230769	0.00013559279024077	0.00791409919038683	0.466845976799004	0.47484595142321	0.384947931493573	0.466845976799004	0.0691569438187057
down	PLA2G10; PLA2G5; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	6	18	33.3333333333333	0.00015633108323798	0.00855424146092831	0.537935257421895	0.547471453499412	0.416622336829221	0.537622595255419	0.0747507937281927
down	DSP; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	6	18	33.3333333333333	0.00015633108323798	0.00855424146092831	0.537935257421895	0.547471453499412	0.416622336829221	0.537622595255419	0.0747507937281927
down	HNF1B; SOX11; FOXF1; RBPMS2; OVOL2; SIX2;	GO:0048557~embryonic digestive tract morphogenesis	6	18	33.3333333333333	0.00015633108323798	0.00855424146092831	0.537935257421895	0.547471453499412	0.416622336829221	0.537622595255419	0.0747507937281927
down	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	7	27	25.9259259259259	0.00016551844926693	0.0088388402261084	0.569052428579714	0.579645609332798	0.427941233113714	0.569052428579714	0.0772377452233597
down	EPCAM; WT1; SDC4; LHX1; FOXC1; SIX1; NPNT; FOXC2;	GO:0001657~ureteric bud development	8	37	21.6216216216216	0.00016910402488556	0.0088388402261084	0.581210533531701	0.592202295149263	0.4323989916324	0.581041429506815	0.0772377452233597
down	FOXN1; FZD6; EGFR; HOXC13; SOX18; LHX2; ALX4; KRT84;	GO:0001942~hair follicle development	8	37	21.6216216216216	0.00016910402488556	0.0088388402261084	0.581210533531701	0.592202295149263	0.4323989916324	0.581041429506815	0.0772377452233597
down	LHX1; HAP1; EN1; CNTN1; FOXC1; CDK5R2; SCN5A; FAIM2; GBX2;	GO:0021549~cerebellum development	9	48	18.75	0.00017334622520315	0.00892733059796236	0.595444283572829	0.60705848066144	0.437559517884336	0.595444283572829	0.0780110137315728
down	IRF6; KLK8; FST; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	5	11	45.4545454545455	0.00017872917648331	0.00907115327600833	0.613755992043709	0.625909576044575	0.444199295456401	0.613755992043709	0.079267800717205
down	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	6	19	31.5789473684211	0.00019951583037924	0.00989274571432996	0.684937845691961	0.698704437988129	0.469859780543131	0.684937845691961	0.0864472434727242
down	IGF2; IL1A; EDN1; BTC; FGF8; EPGN; DMRT1;	GO:0045840~positive regulation of mitotic nuclear division	7	28	25	0.00020056680346014	0.00989274571432996	0.688345269475217	0.702384945717427	0.47113142132788	0.688345269475217	0.0864472434727242
up	IGKV1-12; PSMB11; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGKV1-16; IGKV3-11; IGKV2-30; IGKV4-1; IGHV4-34; IGLC2; IGLC3; FCER1A; IGHV1-2; LILRA4; IGLV3-21; MS4A2; PSMA8;	GO:0038095~Fc-epsilon receptor signaling pathway	44	171	25.7309941520468	0.00022023966048856	0.047089992408211	0.750136283624048	0.753439878531376	0.750136283624048	0.750136283624048	0.410391638283181
down	BIRC5; IL1A; CXCL10; MMP1; MMP3; FGF2; CXCL1; SAA1; LIF; PTPRZ1; NOS2; LCN2; IL13RA2; IL20RB; IFNL1; IL1F10; IL1RAPL2; DUOX2; IL36B; IL36G; IL36RN; IL19; IL20RA; IL37;	GO:0019221~cytokine-mediated signaling pathway	24	278	8.63309352517986	0.0002404094197731	0.0116932470561862	0.824844719241513	0.841913788045404	0.515627785428823	0.824844719241513	0.102180830726155
down	DSP; DSG2; GRHL1; PERP;	GO:0002934~desmosome organization	4	6	66.6666666666667	0.0002828277441409	0.013384631891641	0.970099162403291	0.990462759981436	0.55456875014691	0.96981633465915	0.116960909068292
down	GJA5; ANK2; SCN5A; HCN4;	GO:0086015~SA node cell action potential	4	6	66.6666666666667	0.0002828277441409	0.013384631891641	0.970099162403291	0.990462759981436	0.55456875014691	0.96981633465915	0.116960909068292
down	CAPN8; PIR; AKR1C2; SST; GUCA2B; CTRB2; CYP39A1;	GO:0007586~digestion	7	30	23.3333333333333	0.00028858475675686	0.013474984242167	0.989268546162516	1	0.559565843351552	0.989268546162516	0.117750448380208
down	PLPP2; CERS1; ALDH3B2; HACD2; FA2H; CERS3; ACER1; SPTLC3; ELOVL4;	GO:0030148~sphingolipid biosynthetic process	9	52	17.3076923076923	0.00029419166050148	0.0135560420404764	1	1	0.564553796502352	0.999956706836411	0.118458767731393
down	PLA2G10; PLA2G5; PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	6	21	28.5714285714286	0.00031375132689115	0.01390831831358	1	1	0.581079845075907	0.999956706836411	0.121537115606699
down	CLDN1; CLDN6; CXADR; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	6	21	28.5714285714286	0.00031375132689115	0.01390831831358	1	1	0.581079845075907	0.999956706836411	0.121537115606699
down	SHISA7; CACNG3; CACNG7; MAPK8IP2; CACNG4; SHISA9;	GO:2000311~regulation of AMPA receptor activity	6	21	28.5714285714286	0.00031375132689115	0.01390831831358	1	1	0.581079845075907	0.999956706836411	0.121537115606699
down	GLI2; FST; BMP5; HOXD12; LHX1; SIX1; GRHL3;	GO:0007389~pattern specification process	7	31	22.5806451612903	0.00034294313446081	0.0148269982331084	1	1	0.604608746054418	0.999956706836411	0.129564952263001
down	CA2; ASS1; KRT14; S100A8; HAAO; GGH; SLC30A3;	GO:0010043~response to zinc ion	7	31	22.5806451612903	0.00034294313446081	0.0148269982331084	1	1	0.604608746054418	0.999956706836411	0.129564952263001
down	SFN; CDK5R2; CDKN3; PKMYT1; BCCIP; CCNB2; CCNO; CCNB1; CCNA1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	9	55	16.3636363636364	0.00042471087964424	0.0177063988156444	1	1	0.656652425776221	0.999956706836411	0.154726444370641
down	CCL24; CXCL11; PTGES; VGF; TOM1L1; CXCL14; EGFR; GAST; CXCL10; INHA; FGF1; REG1A; S100A6; MET; NMB; FGF2; CXCL1; CGB7; CHRM1; NTF3; ITPKA; IGFBP6; SFN; S100A11; BTC; GDNF; CEACAM6; GRIA1; GRIA2; BCAM; GNGT1; MST1R; CXCL9; STK3; PKP1; FGFBP1; INSL4; GPNMB; ARTN; EPGN; MACC1; RASSF6; RHPN2; GPRC5A; CASKIN1; CDS1; DIRAS2; DPYSL5; TRIM54; FGF21; CALML5; IL19; CCL26; GABRD; CBLC; PLPP2; GABRB2; PLPPR5; GABRA1;	GO:0007165~signal transduction	59	989	5.96562184024267	0.00043901335343321	0.0180873501614485	1	1	0.663632987156672	0.999956706836411	0.158055367876102
down	EGFR; BMP5; ID1; DLX5; DLX6; HYAL1; SCN5A; EPGN; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	9	57	15.7894736842105	0.00053568153206695	0.0215627209804423	1	1	0.703027381718809	0.999956706836411	0.188424714872697
down	PLA2G10; NMB; PLA2G4F; PLA2G2F; PLA2G3; PLA2G5;	GO:0050482~arachidonic acid secretion	6	24	25	0.00057445424203928	0.0226038062429388	1	1	0.716592156223296	0.999956706836411	0.1975221842469
down	PTGES; CYP26A1; LRAT; TRIM16; RBP4; HSD17B2; TRIML2; RXRG;	GO:0032526~response to retinoic acid	8	46	17.3913043478261	0.00061504105202425	0.0239319307132105	1	1	0.730724544469769	0.999956706836411	0.209127930796855
down	BIRC5; NUPR1; CLDN7; EGFR; CRYAB; HSPB1; SERPINB2; KRT18; CDK1; CEACAM5; GLI2; MIF; EPCAM; DPEP1; WT1; PAX7; MT3; MSX1; AQP1; BTC; MSX2; FLT4; GDNF; ID1; PLK1; ACTC1; VTCN1; BIRC7; FAIM2; PLK2; TREM2; LHX3; HIGD1A; NR2E1;	GO:0043066~negative regulation of apoptotic process	34	489	6.95296523517382	0.0006462261596063	0.0248690550652886	1	1	0.741495853001106	0.999956706836411	0.217316943166895
down	CYP26A1; UGT1A1; CYP2C18; ALDH1A3; CYP2S1; UGT1A7;	GO:0042573~retinoic acid metabolic process	6	25	24	0.00069100598444538	0.0262650911006308	1	1	0.755960546983247	0.999956706836411	0.229516131393184
down	IGF2; IL1A; FGF1; FGF2; FGF5; BTC; FGF8; MACC1;	GO:0051781~positive regulation of cell division	8	47	17.0212765957447	0.00069750241929145	0.0262650911006308	1	1	0.758153200164943	0.999956706836411	0.229516131393184
down	FOXA1; ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	5	16	31.25	0.0007177750755023	0.02674093951499	1	1	0.764520575219848	0.999956706836411	0.233674307992491
down	GCNT3; MUC3A; MUC21; MUC15; MUC16; MUCL1; MUC13; A4GNT; B3GNT3;	GO:0016266~O-glycan processing	9	60	15	0.00074573127739241	0.0274900098255604	1	1	0.773323334655933	0.999956706836411	0.240220019909685
down	HOXB8; HOXD9; HOXD10; NTF4; GDNF; EN1; DMBX1; FOXA2;	GO:0008344~adult locomotory behavior	8	48	16.6666666666667	0.00078863566320719	0.0287687717974124	1	1	0.78439982904824	0.999956706836411	0.25139441483669
down	FOXH1; BMP2; GATA4;	GO:0035054~embryonic heart tube anterior/posterior pattern specification	3	3	100	0.00083047796231683	0.0290833382403355	1	1	0.795150555204873	0.999956706836411	0.254143237323892
down	FZD6; MSX1; MSX2;	GO:0035880~embryonic nail plate morphogenesis	3	3	100	0.00083047796231683	0.0290833382403355	1	1	0.795150555204873	0.999956706836411	0.254143237323892
down	GJA5; CXADR; RYR2;	GO:0098904~regulation of AV node cell action potential	3	3	100	0.00083047796231683	0.0290833382403355	1	1	0.795150555204873	0.999956706836411	0.254143237323892
down	GJA5; ANK2; RYR2;	GO:0098910~regulation of atrial cardiac muscle cell action potential	3	3	100	0.00083047796231683	0.0290833382403355	1	1	0.795150555204873	0.999956706836411	0.254143237323892
down	CTSV; KRT84; GRHL1; SERPINB13; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	5	17	29.4117647058824	0.00090179056288852	0.0312680252597586	1	1	0.813415087725451	0.999956706836411	0.273234011122535
down	CLDN3; CLDN1; OCLN; MARVELD2; POF1B; MARVELD3; CRB3;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.00099296400507054	0.0340917641740885	1	1	0.837068656274465	0.999956706836411	0.297909106639939
down	AKR1B10; LRAT; RBP4; RBP1; RBP3; SDC4; AKR1C3; RDH12; STRA6;	GO:0001523~retinoid metabolic process	9	63	14.2857142857143	0.00101844845898502	0.0346272476054907	1	1	0.843529586202625	0.999956706836411	0.302588400731466
down	FUT1; LHX2; DLX2; SEMA3A; NR2E1;	GO:0021772~olfactory bulb development	5	18	27.7777777777778	0.00111870891285393	0.0369596095548533	1	1	0.862647827205791	0.999956706836411	0.322969624218389
down	GLI2; EN2; BMP5; HNF1B; GBX2;	GO:0030902~hindbrain development	5	18	27.7777777777778	0.00111870891285393	0.0369596095548533	1	1	0.862647827205791	0.999956706836411	0.322969624218389
down	CYP1A1; CCNB1; PDX1; CLDN18; FOXF1; ALX4;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.00115240218316082	0.0377169387423288	1	1	0.868414169292897	0.999956706836411	0.329587505901516
down	EGFR; ASS1; REG1A; FOXF1;	GO:0007494~midgut development	4	10	40	0.00120258167818776	0.0389948244167921	1	1	0.87668204339888	0.999956706836411	0.340754243349403
down	BIRC5; HR; ZIC2; CRYAB; BMP2; WT1; MT3; HOXA7; MSX2; SOX18; ID1; HNF4A; NKX2-1; ID4; LHX1; FOXG1; FOXL2; FOXF2; NR0B2; DEPDC1; ERN2; IFNL1; ESX1; DMBX1; MESP1; SOX7; PRDM16; HMX1; MLXIPL; SIX2; ZNF488; OVOL1; SIX1; ALX1; OVOL2;	GO:0045892~negative regulation of transcription, DNA-templated	35	530	6.60377358490566	0.00125540221011522	0.0403341150442523	1	1	0.885677468527655	0.999956706836411	0.352457564782712
down	PANO1; EI24; BIRC5; GJB6; IL1A; S100A8; CDK1; S100A9; CEACAM5; PAEP; CGB7; DPEP1; PAX3; MT3; KRT20; CEACAM6; IFI27; LGALS7; STK3; SEMA3A; MELK; SIX1; PHLDA2; GDF6; RASSF6; UNC5B; CIDEC; BIRC7; GSDMA; FAIM2; BCL2L14; PTPRH; IL19; TPX2; ATCAY; CASP14;	GO:0006915~apoptotic process	36	552	6.52173913043478	0.0013223960699803	0.0418768345927397	1	1	0.896313423750697	0.999956706836411	0.365938539253231
down	CYP1A1; AOC1; AQP1; MT1X; MT3; MT1B;	GO:0071280~cellular response to copper ion	6	29	20.6896551724138	0.00134933364103185	0.0418768345927397	1	1	0.898848025620489	0.999956706836411	0.365938539253231
down	ALOX12B; PSAPL1; ACER1; ALOXE3; ARV1;	GO:0006665~sphingolipid metabolic process	5	19	26.3157894736842	0.00137196623644775	0.0418768345927397	1	1	0.901238925722493	0.999956706836411	0.365938539253231
down	DLX2; DLX3; DLX5; DLX6; LRRC1;	GO:0009790~embryo development	5	19	26.3157894736842	0.00137196623644775	0.0418768345927397	1	1	0.901238925722493	0.999956706836411	0.365938539253231
down	ADRA1B; GJA5; ANK2; RYR2; HCN4;	GO:0055117~regulation of cardiac muscle contraction	5	19	26.3157894736842	0.00137196623644775	0.0418768345927397	1	1	0.901238925722493	0.999956706836411	0.365938539253231
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.00141480501681934	0.0427124755939771	1	1	0.905475210764379	0.999956706836411	0.373240744644512
down	LIF; EPCAM; MSX1; HOXA7; MSX2; PDX1;	GO:0048863~stem cell differentiation	6	30	20	0.0015709273791118	0.0470204075354659	1	1	0.920637181689066	0.999956706836411	0.410885383672317
down	CYP1A1; WT1; FOXC1; VAX1; HES5; FOXC2; STRA6;	GO:0043010~camera-type eye development	7	42	16.6666666666667	0.00166147427623109	0.0484873576280106	1	1	0.929619703362662	0.999956706836411	0.423704250696146
down	CASQ2; ANK2; SCN5A; SEMA3A; RYR2; HCN4;	GO:0002027~regulation of heart rate	6	31	19.3548387096774	0.00181912272527196	0.0522177687205115	1	1	0.945039935408962	0.999956706836411	0.456302253847045
down	NEK2; CDC20; MISP; BCCIP; TPX2; BIRC5;	GO:0090307~mitotic spindle assembly	6	31	19.3548387096774	0.00181912272527196	0.0522177687205115	1	1	0.945039935408962	0.999956706836411	0.456302253847045
down	MMP1; MMP3; MMP7; MMP10; MMP12; MMP13; KLK6;	GO:0030574~collagen catabolic process	7	43	16.2790697674419	0.00187336737531973	0.0533376629948757	1	1	0.949797259287105	0.999956706836411	0.46608839166917
down	EDN1; SOX11; FOXC1; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	5	21	23.8095238095238	0.00200162619201794	0.0565297977777969	1	1	0.957497507575341	0.999956706836411	0.493982695307968
down	CCNB2; CDK1; CCNB1; PLK1;	GO:0007077~mitotic nuclear envelope disassembly	4	12	33.3333333333333	0.00206555895017591	0.0574094241548891	1	1	0.961337856701234	0.999956706836411	0.501669264616565
down	FGF8; EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	4	12	33.3333333333333	0.00206555895017591	0.0574094241548891	1	1	0.961337856701234	0.999956706836411	0.501669264616565
down	SULT2B1; CYP1A1; CYP2C9; UGT1A1; AKR1C3; SULT1E1; AKR1C2;	GO:0008202~steroid metabolic process	7	44	15.9090909090909	0.00210560527178982	0.0578617274778071	1	1	0.963825844770424	0.999956706836411	0.505621693659917
down	FZD6; ALDH1A3; GBX2; FOXG1; DLX5; DLX6; SIX1; USH1G;	GO:0042472~inner ear morphogenesis	8	57	14.0350877192982	0.00211487753202722	0.0578617274778071	1	1	0.96438415460441	0.999956706836411	0.505621693659917
down	ANK2; SCN5A; HCN4;	GO:0086046~membrane depolarization during SA node cell action potential	3	5	60	0.00220378368021235	0.0598267476597181	1	1	0.969664819293432	0.999956706836411	0.522792920233387
down	EDN1; BMP5; PAX7; HOXD3; LUM; DLX2; HYAL1; HES5;	GO:0051216~cartilage development	8	58	13.7931034482759	0.00233269767004052	0.0627523350429332	1	1	0.977400323746977	0.999956706836411	0.548358013294576
down	CYP1A1; GLI2; BMP2; CCNB1; FOXF1; KLF5; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	7	45	15.5555555555556	0.00235946244817065	0.0627523350429332	1	1	0.979119962978848	0.999956706836411	0.548358013294576
down	KRT18; KRT16; KRT6C; EVPLL; DSP;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.00238523411584945	0.0627523350429332	1	1	0.980331221614126	0.999956706836411	0.548358013294576
down	VGF; GAL; HNF1B; PDX1; MAFA; RIMS2;	GO:0030073~insulin secretion	6	33	18.1818181818182	0.00240330717484905	0.0627523350429332	1	1	0.98155365087661	0.999956706836411	0.548358013294576
down	HOXD9; MSX1; HOXA11; MSX2; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	6	33	18.1818181818182	0.00240330717484905	0.0627523350429332	1	1	0.98155365087661	0.999956706836411	0.548358013294576
down	ID4; FOXG1; ISL1; HES5; ISL2; NOTCH3; NR2E1; HES4;	GO:0045665~negative regulation of neuron differentiation	8	59	13.5593220338983	0.002567710730496	0.0654760151213572	1	1	0.991241266820302	0.999956706836411	0.572158749882828
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00262549117360777	0.0654760151213572	1	1	0.994679003805665	0.999956706836411	0.572158749882828
down	EGFR; SOX11; GRHL3; STRA6;	GO:0061029~eyelid development in camera-type eye	4	13	30.7692307692308	0.00262549117360777	0.0654760151213572	1	1	0.994679003805665	0.999956706836411	0.572158749882828
down	MSX1; MSX2; SOX11; LHX2;	GO:2000678~negative regulation of transcription regulatory region DNA binding	4	13	30.7692307692308	0.00262549117360777	0.0654760151213572	1	1	0.994679003805665	0.999956706836411	0.572158749882828
down	CLDN5; FOXH1; SOX18; SOX11; GJA5; ISL1; SIX1;	GO:0003151~outflow tract morphogenesis	7	46	15.2173913043478	0.00263624161396669	0.0654760151213572	1	1	0.995060746767068	0.999956706836411	0.572158749882828
down	LIF; FLT4; FOXF1; ABCA12; STRA6; ERRFI1;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00274339041464344	0.0676574171273334	1	1	0.999956706836411	0.999956706836411	0.591220817762461
down	GJA5; FOXC1; FOXC2; STRA6; NOTCH3;	GO:0048844~artery morphogenesis	5	23	21.7391304347826	0.00281955825232216	0.0685700902752237	1	1	0.999956706836411	0.999956706836411	0.599196164557478
down	KCNK1; CACNG3; KCNJ4; CACNG7; SCN5A; CACNG6; CACNG4;	GO:0061337~cardiac conduction	7	47	14.8936170212766	0.00293727148482392	0.0709401706196785	1	1	0.999956706836411	0.999956706836411	0.61990698827654
down	ACR; HOXD9; HOXD10; HOXA11; FOXL2; MST1R; DEFB126; SLIRP;	GO:0007338~single fertilization	8	61	13.1147540983607	0.00309296890831812	0.0732893973730873	1	1	0.999956706836411	0.999956706836411	0.64043558397575
down	GABRD; CHRM1; GRIA1; GRIA2; GABRB2; GABRA1;	GO:0060078~regulation of postsynaptic membrane potential	6	35	17.1428571428571	0.00311825248674757	0.0732893973730873	1	1	0.999956706836411	0.999956706836411	0.64043558397575
down	CXADR; FOXC1; DMRT1;	GO:0008354~germ cell migration	3	6	50	0.00321836057705727	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	SOX1; GBX2; FGF8;	GO:0021884~forebrain neuron development	3	6	50	0.00321836057705727	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	CLDN5; CLDN3; CLDN1;	GO:1903348~positive regulation of bicellular tight junction assembly	3	6	50	0.00321836057705727	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	GRM8; CXCL11; DEFB4A; GPR37; RGS5; GPR39; FZD6; OR2J3; RGS20; KCNK2; ADGRL2; GLP2R; GAST; CXCL10; EDN1; NMB; CXCL1; SAA1; CHRM1; ADRA2C; DRD5; GAL; CXCR1; HTR1D; CALCR; SSTR5; ADRA1B; AKR1C3; GPR1; NMU; AKR1C2; DEFB1; SST; GNAI1; CXCL9; P2RY6; ADGRF1; GPR158; NPSR1; ADGRG6; ARHGEF25; ADGRF4; ADGRF2; NGEF; TMEM145; GPRC5A; OR10S1; OR2I1P; OR10A6; GPRC5C; LPAR3; FZD10; INSL5; OR7C2; MRGPRX4; GPR50; CGB7; GPR87; CCL26; MRGPRX3; GNGT1; CCL24;	GO:0007186~G protein-coupled receptor signaling pathway	62	1152	5.38194444444444	0.00325884793357578	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	EDN1; NPPB; BTC; HAS2;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.00328124705446742	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	MMP3; CALCR; MMP12; MMP13;	GO:1904645~response to amyloid-beta	4	14	28.5714285714286	0.00328124705446742	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	BMP5; NKX2-1; FOXA1; OVOL2; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.00330826796129824	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	HNF1B; ISL1; FOXF1; MSLN; MET;	GO:0031016~pancreas development	5	24	20.8333333333333	0.00330826796129824	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	CLDN4; CLDN3; CLDN1; OCLN; DUOX2;	GO:0090303~positive regulation of wound healing	5	24	20.8333333333333	0.00330826796129824	0.0733262936738382	1	1	0.999956706836411	0.999956706836411	0.640758000379281
down	CYP1A1; CYP2C9; UGT1A1; TPMT; UGT1A7;	GO:0017144~drug metabolic process	5	25	20	0.00385503070509541	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	DLX3; GJB3; HSD17B2; PLAC1; LHX3; PHLDA2;	GO:0001890~placenta development	6	37	16.2162162162162	0.00398081968575381	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	NR2E1; SIX1; HNF4A; HNF4G; SIX2; TFAP2C; RXRG;	GO:0048856~anatomical structure development	7	50	14	0.00399949355476248	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	CTSV; SEMA3A; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00404018983212984	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	SOX18; GJA5; FOXC1; FOXC2;	GO:0035050~embryonic heart tube development	4	15	26.6666666666667	0.00404018983212984	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	TACSTD2; SERPINB5; SIX1; HES5;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.00404018983212984	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	RBP4; HOXA11; LHX1; FOXL2;	GO:0060065~uterus development	4	15	26.6666666666667	0.00404018983212984	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	NKX2-1; FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	4	15	26.6666666666667	0.00404018983212984	0.0837203833853177	1	1	0.999956706836411	0.999956706836411	0.731586212274391
down	FGF19; FGF1; FGF2; FGF5; FGFR3; FGF8; FGFBP1; ESRP1; ESRP2;	GO:0008543~fibroblast growth factor receptor signaling pathway	9	79	11.3924050632911	0.00412778348753839	0.0850323398432909	1	1	0.999956706836411	0.999956706836411	0.743050675490477
down	DSP; GJA5; ANK2; DSG2; SCN5A; HCN4;	GO:0086091~regulation of heart rate by cardiac conduction	6	38	15.7894736842105	0.0044728215295472	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	PHGDH; PSPH; PSAT1;	GO:0006564~L-serine biosynthetic process	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	FOXN1; HOXC13; KRT84;	GO:0035878~nail development	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	EDN1; NMB; SOX11;	GO:0046887~positive regulation of hormone secretion	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	FOXN1; FST; KRT17;	GO:0051798~positive regulation of hair follicle development	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	UGT1A1; UGT1A7; UGT1A6;	GO:0052696~flavonoid glucuronidation	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	PROM1; WT1; FOXC2;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.00447644607690423	0.0885678766176193	1	1	0.999956706836411	0.999956706836411	0.773945779555914
down	GLI2; BMP2; ADRA2C; HOXD3; SOX11; FOXG1; FOXA1; GDF6; BRINP1;	GO:0045666~positive regulation of neuron differentiation	9	81	11.1111111111111	0.00479185334180487	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	PTGES; EDN1; MIF; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	TACSTD2; SEMA3A; PTPRR; MARVELD3;	GO:0010633~negative regulation of epithelial cell migration	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	AQP1; RHOD; RND1; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	FGF8; KLK6; KLK14; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	CDC20; KNDC1; CSMD3; RAB17;	GO:0050773~regulation of dendrite development	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	MMP3; DPEP1; MT3; AQP1;	GO:0071732~cellular response to nitric oxide	4	16	25	0.00490940638539827	0.0929337360089987	1	1	0.999956706836411	0.999956706836411	0.812096614589261
down	UGT8; NTF3; ARTN; NTF4; GDNF;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.00513728597600305	0.0962073555506025	1	1	0.999956706836411	0.999956706836411	0.840702968550242
down	GLI2; MSX1; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00513728597600305	0.0962073555506025	1	1	0.999956706836411	0.999956706836411	0.840702968550242
down	GLI2; FST; KRT17; KRT27; FOXQ1;	GO:0031069~hair follicle morphogenesis	5	28	17.8571428571429	0.00587997164494358	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	DIO3; IYD; SLC5A5; DUOX2;	GO:0006590~thyroid hormone generation	4	17	23.5294117647059	0.00589567257597667	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	MAG; DRD5; CACNG3; CACNG4;	GO:0019226~transmission of nerve impulse	4	17	23.5294117647059	0.00589567257597667	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	HSD3B1; AKR1C3; AKR1C2;	GO:0008207~C21-steroid hormone metabolic process	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	SULT1C2; CYP1A1; AOC1;	GO:0009308~amine metabolic process	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	GJB6; GJB1; GJA5;	GO:0016264~gap junction assembly	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	AQP1; SCNN1G; AQP4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	GABRA1; AOC1; GABRB2;	GO:0071420~cellular response to histamine	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	WT1; SEMA3A; DMRT1;	GO:2000020~positive regulation of male gonad development	3	8	37.5	0.00599314938478668	0.106538117489964	1	1	0.999956706836411	0.999956706836411	0.930977794005132
down	SERPINA3; S100A8; S100A9; KRT16; BMP2; MIF; DPEP1; GAL; CARD18; HYAL1; NLRP10; CYP4F11; NOX4; IL37; CXCL1; CCL24; CCL26; CXCL9; IL36G; IL1A; IL36RN; IL1F10; IL36B; CXCL11; CXCL10;	GO:0006954~inflammatory response	25	381	6.56167979002625	0.00616274187229771	0.108566087014208	1	1	0.999956706836411	0.999956706836411	0.948699100129847
down	CXCL11; CXCL10; CXCR1; FOXC1; CCL26; CXCL9; CCL24; CXCL1;	GO:0070098~chemokine-mediated signaling pathway	8	70	11.4285714285714	0.00655919304249064	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	EDN1; GBX2; FGF8; FOXC2; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.00669506982803469	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	HOXC11; HOXA11; GDNF; FGF8; FOXC2;	GO:0001656~metanephros development	5	29	17.2413793103448	0.00669506982803469	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	UQCRQ; PITX3; EN2; MSX1; EN1;	GO:0030901~midbrain development	5	29	17.2413793103448	0.00669506982803469	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
up	CXCL13; HP; IL10; IRF8; DEFB108B; TLR9; STAB1; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-13; IGHV1-24; TRBC1; IGHV1-2; TRBC2; IGHV3-30; IGHA2; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-35; IGHV3-23; HAMP; IGHV4-31; TRDC; IGHV3-38; IGHV3-43; IGKC; IGHV4-39; IGHV3-11; IGHV4-59; IGHV3-16; IGHV1-3; IGHV3-33; IGHG4;	GO:0042742~defense response to bacterium	45	216	20.8333333333333	0.00678276874179551	1	1	1	1	1	1
down	BMP2; SERPINB3; ISL1; FOXC1; BAMBI; ALX1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	6	42	14.2857142857143	0.00689607834188566	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	TSPAN15; EGFR; DLX2; NRARP; CHAC1; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	6	42	14.2857142857143	0.00689607834188566	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	PTGES; AKR1C3; AKR1C2; CYP2S1;	GO:0006693~prostaglandin metabolic process	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	BMP2; LHX1; SCN5A; HES5;	GO:0021537~telencephalon development	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	EDN1; NPNT; NMU; ADRA1B;	GO:0045987~positive regulation of smooth muscle contraction	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	RBP4; BMP5; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	GRIK2; NMU; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	BMP5; FGF8; ISL1; SIX1;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	GJA5; ANK2; SCN5A; RYR2;	GO:0086005~ventricular cardiac muscle cell action potential	4	18	22.2222222222222	0.00700542413444794	0.110258250938262	1	1	0.999956706836411	0.999956706836411	0.963485986497149
down	OVOL1; LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	5	30	16.6666666666667	0.00758602585920387	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	LHX1; FGF8; LHX3; EGFLAM; SEMA3A;	GO:0008045~motor neuron axon guidance	5	30	16.6666666666667	0.00758602585920387	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	FGFR3; MSX1; MMP13; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	5	30	16.6666666666667	0.00758602585920387	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	CLDN5; DSG1; PKP3; PKP1; CDH10; CDH17;	GO:0007043~cell-cell junction assembly	6	43	13.953488372093	0.00762648821144762	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	IDO1; SDC4; GPNMB; IL20RB; VTCN1; PLA2G2F;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.00762648821144762	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	IDO1; HAAO; TDO2;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	EDN1; NPPB; GUCA2B;	GO:0007589~body fluid secretion	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	FUT1; FUT2; FUT9;	GO:0042355~L-fucose catabolic process	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	AKR1B10; AKR1C3; AKR1C2;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	AKR1B10; AKR1C3; AKR1C2;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	ALDH1A3; FOXL2; VAX2;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	UGT1A1; UGT1A7; UGT1A6;	GO:0052697~xenobiotic glucuronidation	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	ASS1; WT1; STRA6;	GO:0060539~diaphragm development	3	9	33.3333333333333	0.00778099913849983	0.111676471241912	1	1	0.999956706836411	0.999956706836411	0.975879030797274
down	S100A11; P2RY6; HAS2; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.00824473260214698	0.115956038444653	1	1	0.999956706836411	0.999956706836411	1
down	WT1; BMP5; HOXD13; FGF8;	GO:0030539~male genitalia development	4	19	21.0526315789474	0.00824473260214698	0.115956038444653	1	1	0.999956706836411	0.999956706836411	1
down	CYP26A1; LRAT; CYP1A1; GATA4;	GO:0033189~response to vitamin A	4	19	21.0526315789474	0.00824473260214698	0.115956038444653	1	1	0.999956706836411	0.999956706836411	1
down	NPPB; FOXC1; FOXC2; ACE2;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.00824473260214698	0.115956038444653	1	1	0.999956706836411	0.999956706836411	1
down	GDNF; GBX2; ISL1; ALX1; OVOL2; SEMA3A;	GO:0001755~neural crest cell migration	6	44	13.6363636363636	0.00841100468907974	0.117821353684629	1	1	0.999956706836411	0.999956706836411	1
down	CENPA; PLK1; SAPCD2; MISP; BCCIP;	GO:0000132~establishment of mitotic spindle orientation	5	31	16.1290322580645	0.0085562030334394	0.118904059615495	1	1	0.999956706836411	0.999956706836411	1
down	ALOX12B; CERS1; FA2H; CERS3; ALOXE3;	GO:0046513~ceramide biosynthetic process	5	31	16.1290322580645	0.0085562030334394	0.118904059615495	1	1	0.999956706836411	0.999956706836411	1
down	CDH16; DSG1; CDH17; PCDHB10; PCDHB11; CDH10;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	6	45	13.3333333333333	0.0092517246114372	0.127557242477374	1	1	0.999956706836411	0.999956706836411	1
down	RHOD; MYO1B; RND1; RND3; PLS3; PLS1;	GO:0051017~actin filament bundle assembly	6	45	13.3333333333333	0.0092517246114372	0.127557242477374	1	1	0.999956706836411	0.999956706836411	1
down	FGF1; ADRA2C; NTF3; MT3; DYNAP;	GO:0032148~activation of protein kinase B activity	5	32	15.625	0.00960887183149239	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	CYP1A1; CYP2C9; UGT1A1; SULT1E1;	GO:0008210~estrogen metabolic process	4	20	20	0.00961928587529703	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; MSX1; SIX1; SIX2;	GO:0042474~middle ear morphogenesis	4	20	20	0.00961928587529703	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	CLDN7; EPCAM; DUOXA2; DUOX2;	GO:2000147~positive regulation of cell motility	4	20	20	0.00961928587529703	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	CHMP4C; NDFIP2; ATP6V0D2;	GO:0007034~vacuolar transport	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	SLC26A4; SLC26A9; SLC26A10;	GO:0019532~oxalate transport	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	BMP5; TCF15; STRA6;	GO:0043583~ear development	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; NMB; LIF;	GO:0046888~negative regulation of hormone secretion	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	ID4; HES5; NR2E1;	GO:0048712~negative regulation of astrocyte differentiation	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	HOXD9; HOXD10; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	HOXC11; HOXA11; HYAL1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	CLDN1; EDN1; FIBIN;	GO:0071548~response to dexamethasone	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	HSPB1; MET; FGF2;	GO:2001028~positive regulation of endothelial cell chemotaxis	3	10	30	0.00985015030254144	0.129195604342697	1	1	0.999956706836411	0.999956706836411	1
down	TCF15; FOXF1; FOXC1; FOXC2; HES7; MESP1;	GO:0001756~somitogenesis	6	46	13.0434782608696	0.0101507153284117	0.132147974275457	1	1	0.999956706836411	0.999956706836411	1
down	CASQ2; MYL2; ACTC1; SCN5A; RYR2; MYLK2;	GO:0060048~cardiac muscle contraction	6	46	13.0434782608696	0.0101507153284117	0.132147974275457	1	1	0.999956706836411	0.999956706836411	1
down	SCNN1G; SLC10A2; SCN5A; FXYD3; SLC5A12; SLC5A5; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	8	77	10.3896103896104	0.0108446394576521	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	CEACAM5; CEACAM6; LGALS7; CXADR; CADM3; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	6	47	12.7659574468085	0.0111100098450516	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	PITX3; GLI2; LIF; EN2; EN1; ISL2;	GO:0048666~neuron development	6	47	12.7659574468085	0.0111100098450516	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	CYP1A1; CYP2C9; CYP2S1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	4	21	19.047619047619	0.0111343729300405	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	FGF2; FGFBP1; FOXC2; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.0111343729300405	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	KLK8; EGFR; UGT8; NYAP1; NTF3; STK3; NTF4;	GO:0048812~neuron projection morphogenesis	7	62	11.2903225806452	0.0113174342332616	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	NKX2-8; S100A6; MAP2; PTPRZ1; CTNNA2; VAX2; ISL2; ISL1;	GO:0007409~axonogenesis	8	78	10.2564102564103	0.0115940574994985	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	KCNK2; MT3; CALCR; AKR1C3; PDX1;	GO:0010942~positive regulation of cell death	5	34	14.7058823529412	0.0119742429793599	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	MSX1; MSX2; SOX11; GATA4; HES5;	GO:0030513~positive regulation of BMP signaling pathway	5	34	14.7058823529412	0.0119742429793599	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	OVOL1; GJB3; KRT9; TCF15; DSP;	GO:0043588~skin development	5	34	14.7058823529412	0.0119742429793599	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	DSCAM; MAP2; CTNNA2; MAPK8IP2; DCDC2;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.0119742429793599	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; BMP5; TTK; GDF6; INHBE; INHA;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	6	48	12.5	0.0121316021400117	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; S100A6; MIF; CCNB1; AQP1; BTC;	GO:0048146~positive regulation of fibroblast proliferation	6	48	12.5	0.0121316021400117	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	FOXH1; FOLR1; SOX18; GATA4; FGF8; MESP1; OVOL2;	GO:0001947~heart looping	7	63	11.1111111111111	0.012198806283839	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	RND1; RHOD; RND3;	GO:0000910~cytokinesis	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	S100A8; S100A9; ELANE;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	FOXH1; ISL1; MESP1;	GO:0003139~secondary heart field specification	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	CXCL11; CXCL10; CCL26;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	FUT1; FUT2; FUT9;	GO:0036065~fucosylation	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; LIF; MAG;	GO:0048711~positive regulation of astrocyte differentiation	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	KRT18; KRT8; STK3;	GO:0097284~hepatocyte apoptotic process	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	DSP; DSG2; RYR2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.0122085781091728	0.132777765646966	1	1	0.999956706836411	0.999956706836411	1
down	HOXD3; BCAM; FREM1; NPNT; LYPD5; MSLN; MSLNL; ITGBL1; LYPD3;	GO:0007160~cell-matrix adhesion	9	96	9.375	0.0127574711361358	0.13786967053524	1	1	0.999956706836411	0.999956706836411	1
down	HOXD3; NKX2-1; FGF8; SIX1;	GO:0030878~thyroid gland development	4	22	18.1818181818182	0.0127948723369369	0.13786967053524	1	1	0.999956706836411	0.999956706836411	1
down	CCNB1; CCNO; CCNA1; CCNB2;	GO:0044772~mitotic cell cycle phase transition	4	22	18.1818181818182	0.0127948723369369	0.13786967053524	1	1	0.999956706836411	0.999956706836411	1
down	UQCRQ; NKX2-1; ID4; DLX2; CDK5R2; LHX5; HSD3B1;	GO:0021766~hippocampus development	7	64	10.9375	0.013128567006315	0.141031416123053	1	1	0.999956706836411	0.999956706836411	1
down	DEFB4A; S100A7; NOS2; DEFB1; LCE3A; NLRP10; DEFB126; DMBT1;	GO:0050829~defense response to Gram-negative bacterium	8	80	10	0.0132062209112407	0.141431760339954	1	1	0.999956706836411	0.999956706836411	1
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; TRDV2; TRDV3; LILRA5; CD300LB; TYROBP; LY86; NCR2; JCHAIN; TRGV3; C4BPA; S100B; NLRP2B; RNASE3; DEFA4; KLRC2; AXL; KIR2DS4; NLRP6; LILRA4; SIGLEC14; NAIP; SLAMF1; CD300E; CLEC6A; TREML4; NLRP9; TICAM2; CLEC10A; ZNF683; LILRA2; DEFB108B; IL27; CLEC4C; RNASE6; PLD4; SIGLEC10; PGLYRP2; CD180; TRGV9; CD209; TLR9; TLR8; APOBEC3C; TLR7; CD84; CLEC4A; TRDC; IGHV3-15; IGHV3-16; IGHV3-35; IGHV3-48; IGHV2-70; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV1-3; TRBC2; IGHV3-30; IGLC3; IGHV3-13; IGHV1-2; IGHV6-1; IGHV5-51; IGHV3-38; IGHV3-7; IGHV3-33; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLC2; IGHV3-74; IGHV1-24; IGHV4-31; IGHG3; BPI; IGHV3-11; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2; IGHV3-43;	GO:0045087~innate immune response	89	505	17.6237623762376	0.013230205578038	1	1	1	1	1	1
down	EGFR; BTC; EPGN; CBLC; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	5	35	14.2857142857143	0.0132929362027467	0.141495023045651	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; FOSL1; TGM1; FOXG1; NR2E1;	GO:0045787~positive regulation of cell cycle	5	35	14.2857142857143	0.0132929362027467	0.141495023045651	1	1	0.999956706836411	0.999956706836411	1
down	UBE2C; BIRC5; PRC1; CCNB2; CDK1; CCNB1; CCNO; NEK2; GNAI1; CCNA1; CDC20; PLK5; CENPW; FIGN; CDCA2; MISP; PPP1R1C; KIF2C; RBBP8; SPC25; FBXL7; TPX2;	GO:0051301~cell division	22	347	6.34005763688761	0.0137038814828134	0.144551183592809	1	1	0.999956706836411	0.999956706836411	1
down	PLA2G10; LIPK; LIPM; LIPH; PLA2G2F; PLA2G3; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.0140710146071286	0.147978057520013	1	1	0.999956706836411	0.999956706836411	1
down	ITPKA; PLK2; JPH3; RIMS4; RIMS2; VGF;	GO:0048167~regulation of synaptic plasticity	6	50	12	0.0143694340746854	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.014567457809517	1	1	1	1	1	1
down	PROM1; DSCAM; LHX1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0146052442014162	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	CYP39A1; CYP26A1; CYP26C1; ARV1;	GO:0016125~sterol metabolic process	4	23	17.3913043478261	0.0146052442014162	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	GLI2; HOXA11; DMBX1; STRA6;	GO:0048589~developmental growth	4	23	17.3913043478261	0.0146052442014162	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; UGT1A1; ISL1; SSTR5;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.0146052442014162	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	REG1A; CACNG7; SYT3; RIMS2;	GO:1903861~positive regulation of dendrite extension	4	23	17.3913043478261	0.0146052442014162	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	BTC; GDNF; FGF8; ISL1; DLX2;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.0147060867188238	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	SOX18; FLT4; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	SOX1; PITX3; SOX11;	GO:0002089~lens morphogenesis in camera-type eye	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	SLC26A4; EDN1; ATP12A;	GO:0006885~regulation of pH	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	C1QL1; EPHA8; RND1;	GO:0016322~neuron remodeling	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	LHX1; FAIM2; LHX5;	GO:0021702~cerebellar Purkinje cell differentiation	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	FGF2; MSX1; MSX2;	GO:0048598~embryonic morphogenesis	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	JPH3; RYR2; JPH1;	GO:0060402~calcium ion transport into cytosol	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	UBE2C; PLK1; CDC20;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	EPCAM; SOX11; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.0148622597597945	0.149133620856161	1	1	0.999956706836411	0.999956706836411	1
down	CHP2; EDN1; DPEP1; AKR1C3; SCN5A; LCE1D; ACER1; SYT3;	GO:0071277~cellular response to calcium ion	8	82	9.75609756097561	0.0149762986332732	0.149848565182065	1	1	0.999956706836411	0.999956706836411	1
down	SHISA7; KLK8; KCNK2; ADGRF1; JPH3; PLK2; NTF3; NTF4;	GO:0007613~memory	8	83	9.63855421686747	0.0159230702007394	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	GLI2; BMP2; FGFR3; HES5; SIX2;	GO:0002062~chondrocyte differentiation	5	37	13.5135135135135	0.0162163666652507	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	ASS1; SERPINA3; SAA1; SAA2; UGT1A1;	GO:0006953~acute-phase response	5	37	13.5135135135135	0.0162163666652507	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	PLK1; CDC20; TRIP13; TTK;	GO:0007094~mitotic spindle assembly checkpoint	4	24	16.6666666666667	0.016569525192952	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	CXCL10; CXCL11; CXCL9; CXCL1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.016569525192952	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	CYP1A1; AOC1; ID1; HYAL1;	GO:0046677~response to antibiotic	4	24	16.6666666666667	0.016569525192952	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	PHGDH; AKR7A3; IDO1; GPX2; HAAO; XDH; NOX4;	GO:0022900~electron transport chain	7	68	10.2941176470588	0.0173584005719302	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	S100A7; HYAL1; NUDT15;	GO:0000302~response to reactive oxygen species	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	PTGES; NUPR1; S100A8;	GO:0002526~acute inflammatory response	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	MSX1; MSX2; FGF8;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	FOXH1; GATA4; ISL1;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	XDH; NUDT15; GDA;	GO:0006195~purine nucleotide catabolic process	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	AKR1B15; HSD3B1; HSD17B2;	GO:0006703~estrogen biosynthetic process	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	KRT6B; GRHL3; VAX2;	GO:0007398~ectoderm development	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	CA2; CA7; HAP1;	GO:0032230~positive regulation of synaptic transmission, GABAergic	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	ID4; DLX2; HES5;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	LHX1; DLX6; STRA6;	GO:0060322~head development	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	GJA5; GATA4; ISL1;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	SOX11; ID1; FGF8;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	CYP1A1; HNF1B; HNF4A;	GO:0070365~hepatocyte differentiation	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	GATA4; ANK2; SCN5A;	GO:0086004~regulation of cardiac muscle cell contraction	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	SHISA7; SHISA9; CACNG4;	GO:0098962~regulation of postsynaptic neurotransmitter receptor activity	3	13	23.0769230769231	0.0178153445619984	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
down	VGF; INHA; FOXL2; FOXC1; DMRTA1;	GO:0001541~ovarian follicle development	5	38	13.1578947368421	0.0178263070572724	0.153762875159034	1	1	0.999956706836411	0.999956706836411	1
up	OR2A1; OR5B21; OR1F1; OR6A2; OR2H2; OR4E1; OR2T7; OR3A1; OR3A4P; OR3A3; OR2B6; OR4D2; OR1Q1; OR4D1; OR2B11; OR2T2; OR52W1; OR2L13; OR2C3; OR2L5; OR2AK2; OR2L3; OR4E2; OR10G2; OR6J1; OR10AD1; OR52B6; OR2D3; OR56B2P; OR52N4; OR56B1; OR52H1; OR52K1; OR52I1; OR13A1; OR1L6; OR1K1; OR5C1; OR1L4; OR1L8; OR1J1; OR9A1P; OR9A4; OR13D1; OR2T34; OR2L8; OR2AJ1; OR2T10; OR2T11; OR2T3; OR10AC1; OR2L2; OR52N5; OR52P1P; OR51Q1; OR52I2; OR1L3; OR2AE1; OR1F12; OR5K1; OR5K2; OR5B2; OR1F2P; OR7D2; OR2B2; OR2AG1; OR10A5; OR10A2; OR10A4; OR2D2; OR51M1; OR51J1; OR51I1; OR51I2; OR52D1; OR1A1; OR51B4;	GO:0050911~detection of chemical stimulus involved in sensory perception of smell	77	435	17.7011494252874	0.0183374628904424	1	1	1	1	1	1
down	PLA2G10; FZD6; NUPR1; FOXH1; ID1; NR0B2; FOXA2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	7	69	10.1449275362319	0.0185500629814969	0.158832079611741	1	1	0.999956706836411	0.999956706836411	1
down	CYP2C9; NUDT15; CYP2C18; CYP2S1;	GO:0042738~exogenous drug catabolic process	4	25	16	0.0186913263499748	0.159262834252097	1	1	0.999956706836411	0.999956706836411	1
down	MYL2; ISL1; FOXC1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	4	25	16	0.0186913263499748	0.159262834252097	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; MT3; AKR1C3; MT1X; MT1B;	GO:0071276~cellular response to cadmium ion	5	39	12.8205128205128	0.0195382923812915	0.165673365421992	1	1	0.999956706836411	0.999956706836411	1
down	ASS1; WT1; AQP1; SLC5A5; NOX4; HCN4;	GO:0071320~cellular response to cAMP	6	54	11.1111111111111	0.0196750642184099	0.166430132591477	1	1	0.999956706836411	0.999956706836411	1
down	EFNA3; SIX1; NTF3; NTF4;	GO:0045664~regulation of neuron differentiation	4	26	15.3846153846154	0.0209738333722121	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	ALG3; ALG14; SRD5A3;	GO:0006488~dolichol-linked oligosaccharide biosynthetic process	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	GPRC5A; ERRFI1; CBLC;	GO:0007175~negative regulation of epidermal growth factor-activated receptor activity	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	MAG; ID4; HES5;	GO:0022010~central nervous system myelination	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	NCAN; HYAL1; HYAL4;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	FOXH1; FGF8; SIX1;	GO:0035909~aorta morphogenesis	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	AKR1C3; ALDH1A3; SDR16C5;	GO:0042574~retinal metabolic process	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	IL1A; CDK1; SOD3;	GO:0046688~response to copper ion	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	AGR2; EGFR; STRA6;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	UGT1A6; UGT1A1; UGT1A7;	GO:0052695~cellular glucuronidation	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	SLC26A4; SLC26A9; SLC26A10;	GO:1902358~sulfate transmembrane transport	3	14	21.4285714285714	0.0210703131452099	0.17321182308574	1	1	0.999956706836411	0.999956706836411	1
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.0211844012997406	0.173741857966491	1	1	0.999956706836411	0.999956706836411	1
down	PIGR; KRT1; HSPB1; AZGP1; ZG16B;	GO:0001895~retina homeostasis	5	40	12.5	0.0213545559008226	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	CRYAB; DPEP1; MT3; AQP1; SFN; BIRC7; BIRC5;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	7	72	9.72222222222222	0.0224668997418076	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	CRYAB; CXCL10; PAX3; MSX1; TEAD4; MKX; ALX4; JPH1;	GO:0007517~muscle organ development	8	89	8.98876404494382	0.0225289350150926	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	MRPS12; MRPS35; MRPS15; MRPL14; GADD45GIP1; MRPL13; MRPL18; MRPL47;	GO:0070125~mitochondrial translational elongation	8	89	8.98876404494382	0.0225289350150926	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	MRPS12; MRPS35; MRPS15; MRPL14; GADD45GIP1; MRPL13; MRPL18; MRPL47;	GO:0070126~mitochondrial translational termination	8	89	8.98876404494382	0.0225289350150926	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	PLA2G10; PLA2G5; PLA2G4D; LIPH; PLA2G2F;	GO:0006654~phosphatidic acid biosynthetic process	5	41	12.1951219512195	0.023277175653028	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	PLA2G10; ALOX12B; ALOXE3; CYP4F11;	GO:0019369~arachidonic acid metabolic process	4	27	14.8148148148148	0.0234198091314153	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	GAL; DEFB1; ADGRG6; RIMS2;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.0234198091314153	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	STK3; TEAD4; WWC1; AMOTL2;	GO:0035329~hippo signaling	4	27	14.8148148148148	0.0234198091314153	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	DRD5; GJA5; GUCA2B; NOS2;	GO:0045776~negative regulation of blood pressure	4	27	14.8148148148148	0.0234198091314153	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	AKR1C3; XDH; ACE2; NOX4;	GO:2000379~positive regulation of reactive oxygen species metabolic process	4	27	14.8148148148148	0.0234198091314153	0.174364590479121	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; INHA; WT1; HOXA11; AKR1C3; GATA4; TFAP2C; ZFP42;	GO:0008584~male gonad development	8	90	8.88888888888889	0.0237927546382177	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	BIRC5; SLC25A5; NEK2; CENPW; CDCA2; SPC25; TTK;	GO:0007059~chromosome segregation	7	73	9.58904109589041	0.0238903270176352	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	FLT4; ROS1; EPHA8; MET; EGFR; MST1R; FGFR3;	GO:0033674~positive regulation of kinase activity	7	73	9.58904109589041	0.0238903270176352	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	GPR37; NMB; CPE; NMU; NPSR1; GAL; GPR1; NPPB; SSTR5;	GO:0007218~neuropeptide signaling pathway	9	108	8.33333333333333	0.0241621510777044	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	KCNK2; CCNB1; FOSL1; GATA4; PSPH; SOST;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.0244335858402082	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; EDN1; ELANE; HES5; RBPMS2; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	6	57	10.5263157894737	0.0244335858402082	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	GGCT; GGT6; CHAC1;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	S100A8; MT3; LAMC3;	GO:0014002~astrocyte development	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	SERPINA3; RBP4; MUC13;	GO:0030277~maintenance of gastrointestinal epithelium	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	ENTPD3; ENTPD8; NUDT15;	GO:0034656~nucleobase-containing small molecule catabolic process	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	SHISA9; GRIK2; SHISA7;	GO:0048172~regulation of short-term neuronal synaptic plasticity	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	SOX11; GDNF; SEMA3A;	GO:0048485~sympathetic nervous system development	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	CA2; ACR; SST;	GO:0048545~response to steroid hormone	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	KRT1; KRT10; FARSB;	GO:0051290~protein heterotetramerization	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; ACTC1; MYLK2;	GO:0055008~cardiac muscle tissue morphogenesis	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	KCNK2; RBP4; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	RBP4; OVOL2; ADGRG6;	GO:0060347~heart trabecula formation	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	NIPAL4; NIPAL1; CLDN16;	GO:1903830~magnesium ion transmembrane transport	3	15	20	0.0246281263633775	0.174590482843215	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; BRINP1; INHA; BMP2; CAMK2N1;	GO:0045786~negative regulation of cell cycle	5	42	11.9047619047619	0.0253080711141299	0.178687227906619	1	1	0.999956706836411	0.999956706836411	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0254238788048499	1	1	1	1	1	1
down	IL1A; FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	4	28	14.2857142857143	0.0260315981536254	0.182690694857708	1	1	0.999956706836411	0.999956706836411	1
down	MSX1; MSX2; FGF8; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	4	28	14.2857142857143	0.0260315981536254	0.182690694857708	1	1	0.999956706836411	0.999956706836411	1
up	FN1; MMP2; HMGA2; COL7A1; LAMB3; LAMA3; NODAL; COL12A1; MIXL1;	GO:0035987~endodermal cell differentiation	9	28	32.1428571428571	0.0264025487589545	1	1	1	1	1	1
down	CLDN4; EGFR; ASS1; NOS2; NR0B2; ATOH7; ARNTL2;	GO:0007623~circadian rhythm	7	75	9.33333333333333	0.0269204661811855	0.188550945133023	1	1	0.999956706836411	0.999956706836411	1
down	DSP; CDH17; CADM3; NECTIN4; CDH10;	GO:0034332~adherens junction organization	5	43	11.6279069767442	0.0274490005064233	0.19186906142414	1	1	0.999956706836411	0.999956706836411	1
down	SERPINA3; PIGR; SLPI; KRT1; S100A8; S100A9; ELANE; CXCL1; MIF; DSP; AOC1; TCN1; CXCR1; SERPINB3; S100A7; S100A11; CEACAM6; CRISP3; LCN2; FABP5; DSG1; PKP1; FLG2; HRNR; GGH; SERPINB12; CALML5;	GO:0043312~neutrophil degranulation	27	483	5.59006211180124	0.0278222423435267	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	GRM8; GPR37; EDN1; HTR1D; GNAI1; PSAPL1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	6	59	10.1694915254237	0.0279995126963855	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; DPEP1; MT3; CERS1; NOS2; FGF21;	GO:0035690~cellular response to drug	6	59	10.1694915254237	0.0279995126963855	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; HNF4A; GDF6; INHA; BMP5; INHBE;	GO:0060395~SMAD protein signal transduction	6	59	10.1694915254237	0.0279995126963855	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	CLDN3; RAB25; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	MT1X; MT1B; MT3;	GO:0010273~detoxification of copper ion	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	CNTN1; SCN5A; PRSS8;	GO:0010765~positive regulation of sodium ion transport	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	HMMR; FGF2; HYAL1;	GO:0030214~hyaluronan catabolic process	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	FOLR1; MAG; ISL1;	GO:0031103~axon regeneration	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; NOX4; DUOX2;	GO:0042554~superoxide anion generation	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	TRIM16; FOXC1; OVOL2;	GO:0045618~positive regulation of keratinocyte differentiation	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; GRIK2; MAPK8IP2;	GO:0046328~regulation of JNK cascade	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	GLI2; FOXF2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	RIMS2; SYT3; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	DSCAM; VSTM2L; MYPN;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.0284883644630065	0.192598942759554	1	1	0.999956706836411	0.999956706836411	1
down	FGFR3; MMP13; DLX5; FOXC1;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.0288111328445058	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; FOXC1; BRINP1; BTG4;	GO:0045930~negative regulation of mitotic cell cycle	4	29	13.7931034482759	0.0288111328445058	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	CXCL11; CXCL10; CXCL9; NPSR1;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.0288111328445058	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	ELANE; DRD5; ANK2; GRIK2; RYR2; STOML2; STC2; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	8	94	8.51063829787234	0.0293449658944979	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; FGFR3; MMP13; GPNMB; TUFT1;	GO:0030282~bone mineralization	5	44	11.3636363636364	0.0297015587216999	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	NKX2-8; NUPR1; KRT4; ISL1; MARVELD3; A4GNT;	GO:0050680~negative regulation of epithelial cell proliferation	6	60	10	0.0299044901614068	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	SMIM22; GRHL3; FZD10; RND3; RND1; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	7	77	9.09090909090909	0.030201733853587	0.193224184979346	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; ADRA2C; GJA5; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.0317599412467257	0.199324935924791	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; SOX11; VAX1; DMRTA2; MYLK2;	GO:0035914~skeletal muscle cell differentiation	5	45	11.1111111111111	0.0320671758364148	0.200893112306127	1	1	0.999956706836411	0.999956706836411	1
down	CDC42EP2; CLDN1; ASS1; EDN1; NOS2; AQP4; CCL24; CCL26;	GO:0071346~cellular response to interferon-gamma	8	96	8.33333333333333	0.0324302421024443	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	AQP1; AQP5; AQP4;	GO:0006833~water transport	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	MAP2; MAG; MT3;	GO:0030517~negative regulation of axon extension	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	METTL5; TFB2M; FBLL1;	GO:0031167~rRNA methylation	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	SDC4; USH1G; HES5;	GO:0060122~inner ear receptor cell stereocilium organization	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	DRD5; GRIA1; PLK2;	GO:0060292~long-term synaptic depression	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
down	SIX1; VSTM2A; PRDM16;	GO:0090336~positive regulation of brown fat cell differentiation	3	17	17.6470588235294	0.0326493570649236	0.20201068629216	1	1	0.999956706836411	0.999956706836411	1
up	LPXN; FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0330455031602357	1	1	1	1	1	1
down	CCNB1; TTK; SPC25; PLK2; BCCIP;	GO:0007052~mitotic spindle organization	5	46	10.8695652173913	0.0345471161870057	0.212625660609655	1	1	0.999956706836411	0.999956706836411	1
down	PTGES; CDK1; HNF1B; LUM; FGF8;	GO:0014070~response to organic cyclic compound	5	46	10.8695652173913	0.0345471161870057	0.212625660609655	1	1	0.999956706836411	0.999956706836411	1
down	GJB6; CXCL14; BMP2; SIX1; LHX3;	GO:0048839~inner ear development	5	46	10.8695652173913	0.0345471161870057	0.212625660609655	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; HOXD13; PSPH; CA9;	GO:0033574~response to testosterone	4	31	12.9032258064516	0.03487915613544	0.212799311474409	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; BTC; MATK; PTPRR;	GO:0038128~ERBB2 signaling pathway	4	31	12.9032258064516	0.03487915613544	0.212799311474409	1	1	0.999956706836411	0.999956706836411	1
down	FGF2; FGFR3; EPHA8; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.03487915613544	0.212799311474409	1	1	0.999956706836411	0.999956706836411	1
down	CLDN5; MSX1; DLX5; STRA6;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.03487915613544	0.212799311474409	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; ASS1; AQP1; ERRFI1;	GO:0071549~cellular response to dexamethasone stimulus	4	31	12.9032258064516	0.03487915613544	0.212799311474409	1	1	0.999956706836411	0.999956706836411	1
down	CTSV; CRYAB; EDN1;	GO:0010259~multicellular organism aging	3	18	16.6666666666667	0.0371083044797615	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	RAET1G; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	3	18	16.6666666666667	0.0371083044797615	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	SULT2B1; SULT1C2; SULT1E1;	GO:0050427~3'-phosphoadenosine 5'-phosphosulfate metabolic process	3	18	16.6666666666667	0.0371083044797615	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	GDNF; LHX1; SIX1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.0371083044797615	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	FGF1; FGF2; FUT1;	GO:1903672~positive regulation of sprouting angiogenesis	3	18	16.6666666666667	0.0371083044797615	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	PRC1; MAP2; PLK1; CAPN6;	GO:0001578~microtubule bundle formation	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	BRINP1; GRIK2; MAPK8IP2; NR2E1;	GO:0001662~behavioral fear response	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	LIF; FGF8; FOXC1; FOXC2;	GO:0001974~blood vessel remodeling	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	SLC6A15; SLC6A14; SLC6A2; SLC6A11;	GO:0006810~transport	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	SCNN1G; GUCA2B; UGT1A7; CLDN16;	GO:0007588~excretion	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	KRT1; FGF2; ID1; GPNMB;	GO:0045765~regulation of angiogenesis	4	32	12.5	0.0381695252732157	0.214533206761782	1	1	0.999956706836411	0.999956706836411	1
down	EGFR; S100A8; S100A9; SFN; KRT17; HYAL1; SLC44A4;	GO:0030307~positive regulation of cell growth	7	82	8.53658536585366	0.0395509033453112	0.219504379580475	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; MET; MT3; GATA4; TREM2;	GO:0010507~negative regulation of autophagy	5	48	10.4166666666667	0.0398541934111811	0.220837635009425	1	1	0.999956706836411	0.999956706836411	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0406058201869686	1	1	1	1	1	1
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.0406058201869686	1	1	1	1	1	1
down	AQP1; AQP5; FGF8; TUFT1;	GO:0042476~odontogenesis	4	33	12.1212121212121	0.0416314226599988	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	HOXD8; HOXC8; TBX4; TCF15;	GO:0048705~skeletal system morphogenesis	4	33	12.1212121212121	0.0416314226599988	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	BMP2; DLX5; VSTM2A; GATA5;	GO:0071773~cellular response to BMP stimulus	4	33	12.1212121212121	0.0416314226599988	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	PDX1; MAFA; NOS2;	GO:0007263~nitric oxide mediated signal transduction	3	19	15.7894736842105	0.0418613908500809	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	MYO5B; MYO1A; MYO1B;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0418613908500809	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	HOXD10; STRA6; HOXC10;	GO:0050905~neuromuscular process	3	19	15.7894736842105	0.0418613908500809	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	NTF4; GABRB2; ISL1;	GO:0060384~innervation	3	19	15.7894736842105	0.0418613908500809	0.229418764877908	1	1	0.999956706836411	0.999956706836411	1
down	RIMS4; POPDC3; RIMS2; HCN4; GABRB2; GABRD; GABRA1; KCNH5;	GO:0042391~regulation of membrane potential	8	102	7.84313725490196	0.0429896420919766	0.235233947822035	1	1	0.999956706836411	0.999956706836411	1
up	ITGB4; LAMB3; LAMC2; LAMA3; COL17A1;	GO:0031581~hemidesmosome assembly	5	12	41.6666666666667	0.0430098518103904	1	1	1	1	1	1
down	SLPI; S100A8; S100A9; KRT16; SAA1; MIF; C4BPB; S100A7; IFI27; CRISP3; DEFB1; LCN2; MST1R; NLRP10; PYDC1; PGLYRP4; PGLYRP3; DEFB126; PLA2G2F; TRIM31; TREM2; IL36B; IL36G; IL36RN; DMBT1; IFNL1; IGLL1;	GO:0045087~innate immune response	27	505	5.34653465346535	0.0432325867408648	0.236194257046035	1	1	0.999956706836411	0.999956706836411	1
down	CXCL11; CXCL10; DRD5; CALCR; CXCL9; ADGRF1; ADGRG6; ADGRL2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	8	103	7.76699029126214	0.0449459376392919	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
up	OXT; DRD2; APLN; MMP17;	GO:0042756~drinking behavior	4	8	50	0.0450103198358278	1	1	1	1	1	1
down	EGFR; PIGR; BTC; FAM83B; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	5	50	10	0.0456295879135526	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	CCNB1; TRIP13; TUBB8;	GO:0001556~oocyte maturation	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	EDN1; NMU; RYR2;	GO:0010460~positive regulation of heart rate	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	CASQ2; ANK2; RYR2;	GO:0010881~regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	HYAL1; HAS2; ERRFI1;	GO:0036120~cellular response to platelet-derived growth factor stimulus	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	FOXN1; FLT4; ID1;	GO:0048514~blood vessel morphogenesis	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	GJA5; ANK2; SCN5A;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	3	20	15	0.0469038895872663	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	HSPB1; CYP1A1; FOSL1; LCN2; MST1R; HYAL1; BATF3; DUOX2;	GO:0009615~response to virus	8	104	7.69230769230769	0.0469597299887298	0.240562349540305	1	1	0.999956706836411	0.999956706836411	1
down	KCNK1; AQP1; GJA5; KCNJ4; FXYD3; KCNF1;	GO:0006813~potassium ion transport	6	68	8.82352941176471	0.0482084518771209	0.241222935926657	1	1	0.999956706836411	0.999956706836411	1
down	CLDN4; PSG2; IDO1; FOSL1; ADRA2C; PSG9; PSG7;	GO:0007565~female pregnancy	7	86	8.13953488372093	0.0482582101300286	0.241222935926657	1	1	0.999956706836411	0.999956706836411	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0490695026457071	0.241222935926657	1	1	0.999956706836411	0.999956706836411	1
down	FGF2; BMP2; WT1; KLF5;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	4	35	11.4285714285714	0.0490695026457071	0.241222935926657	1	1	0.999956706836411	0.999956706836411	1
down	NUPR1; S100A8; S100A9; IL20RA;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	4	35	11.4285714285714	0.0490695026457071	0.241222935926657	1	1	0.999956706836411	0.999956706836411	1
up	LILRA5; IFNG; ORM1; LPL; ORM2; WNT5A; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.0493756395971586	1	1	1	1	1	1
